| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 08/26/2009 | CN100531736C Application of 9 - (2 - hydroxyethoxy methyl)guanine in preparing silkworm drug |
| 08/26/2009 | CN100531735C Novel technique of preparing lactic acid ciprofloxacin injection |
| 08/26/2009 | CN100531725C Composition of aiphenyl hepatanone compound and its use |
| 08/26/2009 | CN100531714C Preparing method of concentrated Shuanghuanglian oral liquid |
| 08/25/2009 | US7579471 Tropane derivatives useful in therapy |
| 08/25/2009 | US7579465 For treatment of picornavirus infections in mammals |
| 08/25/2009 | US7579439 Modulation of IL-2- and IL-15-mediated T cell responses |
| 08/25/2009 | US7579432 Cyclic peptides as G-protein-coupled receptor antagonists |
| 08/25/2009 | US7579362 3-(6-p-Tolyl-pyridin-3-yloxy)-1-aza-bicyclo[2.2.2]octane; treatment of psychotic disorders such as schizophrenia, mania, depression and anxiety; neurodegenerataive disorders such as senile dementia, Alzhelmer's disease and other intellectual impairment disorders |
| 08/25/2009 | US7579357 Antidiabetic agents; obesity; controlling appetite |
| 08/25/2009 | US7579347 Vanilloid receptor ligands and their use in treatments |
| 08/25/2009 | US7579332 Nucleobase phosphonate analogs for antiviral treatment |
| 08/25/2009 | US7579325 Drugs containing reduced of vitamin B2 |
| 08/25/2009 | US7579182 against tularemia; subcellular protein expressed from Francisella tularensis infected mammal subculture growing in synthetic salts medium of weak acidity |
| 08/25/2009 | US7579170 Method for preparing monoclonal antibodies capable of activating effector cells expressing FCγRIII |
| 08/25/2009 | US7579141 Method of in vitro diagnosis which discriminates between exposure of a subject to Mycobacterium tuberculosis and vaccination with Bacille Calmette Guerin strain of Mycobacterium bovis, method comprising testing for presence of CD4 T lymphocytes that respond to MTBN4 |
| 08/25/2009 | US7579003 HBsAg-BCG combined vaccine for intracutaneous injection and preparation method thereof |
| 08/25/2009 | US7579001 Antagonists of TWEAK and of TWEAK receptor and their use to treat immunological disorders |
| 08/25/2009 | CA2563965C 6-0-substituted ketolides having antibacterial activity |
| 08/25/2009 | CA2426680C Process for formulation of antibiotic compounds |
| 08/25/2009 | CA2388163C Process for formulation of carbapenem antibiotic compositions |
| 08/25/2009 | CA2385302C Receptor proteins specifically recognizing bacterial dna |
| 08/25/2009 | CA2382521C Oligonucleotide n3'.fwdarw.p5' thiophosphoramidates: their synthesis and use |
| 08/25/2009 | CA2372456C Viral infection inhibitor targeting integrase n-terminal domain |
| 08/25/2009 | CA2269246C Substituted tricyclics |
| 08/20/2009 | WO2009103053A1 Fluoroquinolone derivatives for ophthalmic applications |
| 08/20/2009 | WO2009103035A2 Templated open flocs of anisotropic particles for enhanced pulmonary delivery |
| 08/20/2009 | WO2009102814A2 Mucosally non-irritative liquid amphotericin b formulations and methods for treating non-invasive fungus-induced mucositis |
| 08/20/2009 | WO2009102715A2 Peptide therapy for ocular herpes infections |
| 08/20/2009 | WO2009102694A1 Heterocyclic derivatives as hepatitis c virus inhibitors |
| 08/20/2009 | WO2009102633A1 Hepatitis c virus inhibitors |
| 08/20/2009 | WO2009102568A1 Conformationally restricted biphenyl derivatives for use as hepatitis c virus inhibitors |
| 08/20/2009 | WO2009102497A2 Genetic regulation of host defense mechanisms by mucosal exposure to natural interferon alpha species |
| 08/20/2009 | WO2009102325A1 Imidazolyl biphenyl imidazoles as hepatitis c virus inhibitors |
| 08/20/2009 | WO2009102318A1 Hepatitis c virus inhibitors |
| 08/20/2009 | WO2009102229A1 Lipid-protein raft complex made of the influenza a virus shell for anti-influenza vaccines and a method for the isolation thereof, a method for producing virus-like particles from such complexes |
| 08/20/2009 | WO2009102050A1 Intestinal immune system stimulator |
| 08/20/2009 | WO2009102008A1 Low-molecular-weight substance derived from maitake mushroom and having immunostimulating activity and anti-tumor activity |
| 08/20/2009 | WO2009101453A1 Compositions and methods of cure and prophylaxis of hiv/aids and related syndromes |
| 08/20/2009 | WO2009101345A1 Novel anti-infectious derivatives, method for the production thereof, pharmaceutical compositions containing same and uses of said derivatives in treatment |
| 08/20/2009 | WO2009101022A1 Heterocyclic antiviral compounds |
| 08/20/2009 | WO2009100955A1 Antisense rna targeting cxcr4 |
| 08/20/2009 | WO2009100949A1 Zwitterionic guanidinium compounds as selective antimicrobial active ingredients |
| 08/20/2009 | WO2009100890A1 Products made of o-acylated hydroxycarboxylic acids and amino acids, the production, biological activities, cosmetically or pharmaceutically effective compositions and use thereof, particularly as food additives, and as cosmetic additives |
| 08/20/2009 | WO2009100723A2 Crystalline forms of an antibiotic substance |
| 08/20/2009 | WO2009100532A1 NOVEL 17ß LUPANE DERIVATIVES |
| 08/20/2009 | WO2009079412A3 Reverse transcriptase inhibitors |
| 08/20/2009 | WO2009071905A3 Use of thiolatocobalamins as regulators/selective promoters of inducible and constitutive nitric oxide synthases |
| 08/20/2009 | WO2009046872A3 Use of a peptide as a therapeutic agent |
| 08/20/2009 | WO2009043354A3 Combination treatment for the treatment of hepatitis c virus infection |
| 08/20/2009 | WO2009033808A3 Use of a peptide as a therapeutic agent |
| 08/20/2009 | WO2009033789A3 Use of a peptide as a therapeutic agent |
| 08/20/2009 | WO2009033765A3 Use of a peptide as a therapeutic agent |
| 08/20/2009 | WO2009033754A3 Use of a peptide as a therapeutic agent |
| 08/20/2009 | WO2009030684A3 Reduction of concomitant infections in pigs by the use of pcv2 antigen |
| 08/20/2009 | WO2009029317A3 Compositions for regulating or modulating quorum sensing in bacteria, methods of using the compounds, and methods of regulating or modulating quorum sensing in bacteria |
| 08/20/2009 | WO2009003463A3 Use of deuterium oxide for treating virus-based skin diseases |
| 08/20/2009 | WO2009002372A3 Prevention and treatment of gram negative, flagellated bacterial infections |
| 08/20/2009 | WO2008092690A8 Aminoglycoside antibiotics targeting bacterial 16s ribosomal rna |
| 08/20/2009 | US20090209640 Prevention of and countermeasures against viral infection |
| 08/20/2009 | US20090209593 Novel antibacterial agents |
| 08/20/2009 | US20090209586 Piperidine derivatives as human papilloma virus inhibitors |
| 08/20/2009 | US20090209584 Antibacterial mutilins |
| 08/20/2009 | US20090209583 2-(substituted-amino)-benzothiazole sulfonamide hiv protease inhibitors |
| 08/20/2009 | US20090209578 Chemical compounds |
| 08/20/2009 | US20090209559 Pharmaceutical compounds |
| 08/20/2009 | US20090209530 Inhibitors of cyclin-dependent kinases, compositions and uses related thereto |
| 08/20/2009 | US20090209508 Compounds for Photochemotherapy |
| 08/20/2009 | US20090209481 Nucleoside prodrugs and uses thereof |
| 08/20/2009 | US20090209464 inhibiting Flavivirus infection by inhibiting the fusion between the virion envelope and a cell membrane; E1 envelope glycoprotein of hepaciviruses and E2 envelope glycoprotein of pestivirus have previously undescribed structures, truncated class II fusion proteins |
| 08/20/2009 | US20090208598 Use of a combination of ethanolic rosa sp., urtica dioica and tanacetum vulgare extracts, further compromising selenium and urea and having been exposed to a pulsed electromagnetic field, for the preparation of a medicament for immunostimulation and/or treatment of hiv infections |
| 08/20/2009 | US20090208581 Formulations limiting spread of pulmonary infections |
| 08/20/2009 | US20090208580 Functionalized dendrimer-encapsulated and dendrimer-stabilized nanoparticles |
| 08/20/2009 | US20090208533 Neisseria meningitidis serogroup a capsular polysaccharide acetyltransferase, methods and compositions |
| 08/20/2009 | US20090208528 Empty capsids (vlps(-vp4)) of the infectious bursal disease virus (ibdv), obtainment process and applications |
| 08/20/2009 | US20090208523 Adjuvant for vaccines |
| 08/20/2009 | US20090208519 Novel Neospora caninum Vaccine |
| 08/20/2009 | US20090208516 Promoter for introducing a gene into a lymphocyte or blood cell and application thereof |
| 08/20/2009 | US20090208485 To treat inflammatory diseases, immune diseases and cancer; N-[(1R,3S)-3-isopropyl-3-9{4-[3-(trifluoromethyl)phenyl]piperazin-1-yl}carbonyl)cyclopentyl]tetrahydro-2H-pyran-4-amine; side effect reduction; improved long term safety profile; oral administration; half life |
| 08/20/2009 | US20090208476 Compositions and methods to concurrently treat or prevent multiple diseases with cupredoxins |
| 08/20/2009 | US20090208457 Tricyclic-Nucleoside Prodrugs for Treating Viral Infections |
| 08/20/2009 | US20090208449 Heterocyclic antiviral compounds |
| 08/20/2009 | DE102008010362A1 Sgk1 als therapeutisches und diagnostisches Target für virale Erkrankungen Sgk1 as therapeutic and diagnostic target for viral diseases |
| 08/20/2009 | CA2723314A1 Templated open flocs of anisotropic particles for enhanced pulmonary delivery |
| 08/20/2009 | CA2715839A1 Imidazolyl biphenyl imidazoles as hepatitis c virus inhibitors |
| 08/20/2009 | CA2715559A1 Hepatitis c virus inhibitors |
| 08/20/2009 | CA2715550A1 Conformationally restricted biphenyl derivatives for use as hepatitis c virus inhibitors |
| 08/20/2009 | CA2715400A1 Heterocyclic derivatives as hepatitis c virus inhibitors |
| 08/20/2009 | CA2715367A1 Hepatitis c virus inhibitors |
| 08/20/2009 | CA2715294A1 Genetic regulation of host defense mechanisms by mucosal exposure to natural interferon alpha species |
| 08/20/2009 | CA2715138A1 Novel anti-infectious derivatives, method for the production thereof, pharmaceutical compositions containing same and uses of said derivatives in treatment |
| 08/20/2009 | CA2714580A1 Fluoroquinolone derivatives for ophthalmic applications |
| 08/20/2009 | CA2714254A1 Heterocyclic antiviral compounds |
| 08/20/2009 | CA2714049A1 Novel 17.beta. lupane derivatives |
| 08/19/2009 | EP2090589A1 Albumin-fused Kunitz domain peptides |
| 08/19/2009 | EP2090571A1 Pyrimidine derivates, medicaments comprising them, their use and process of their preparation |
| 08/19/2009 | EP2090334A2 Imidazole based compounds, compositions comprising them and methods of their use |
| 08/19/2009 | EP2090177A1 Food products having enhanced cocoa polyphenol content |
| 08/19/2009 | EP2090169A1 Nucleic acid-degrading agent and method for degradation of nucleic acid |
| 08/19/2009 | EP2090165A2 Antifungal composition with enhanced bioavailability |